Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

BACKGROUND: HER2 status is a predictive biomarker of response to trastuzumab in advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. However, there is relatively little known about the role of HER2 in resected gastric or GEJ adenocarcinoma in the Western population. METHODS: Retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lago, Nieves Martínez, Villar, María Vieito, Ponte, Rafael Varela, Nallib, Ihab Abdulkader, Alvarez, Juan José Carrera, López, José Ramón Antúnez, López, Rafael López, Iruegas, María Elena Padin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105341/
https://www.ncbi.nlm.nih.gov/pubmed/32256703
http://dx.doi.org/10.3332/ecancer.2020.1020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105341/
https://www.ncbi.nlm.nih.gov/pubmed/32256703
http://dx.doi.org/10.3332/ecancer.2020.1020

Ejemplares similares